Discovery of <i>trans</i>-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4<i>S</i>)-methoxy-(2<i>S</i>)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist
Fumihito Muro(Daiichi-Sankyo (Japan)), Nobuo Machinaga(Daiichi-Sankyo (Japan)), Toshiyuki Watanabe(Daiichi-Sankyo (Japan)), Gensuke Takayama(Daiichi-Sankyo (Japan)), Masaki Setoguchi(Daiichi-Sankyo (Japan)), Atsushi Satoh(Kobe Pharmaceutical University), Yuuichi Sugimoto(Daiichi-Sankyo (Japan)), Yutaka Iigou(Daiichi-Sankyo (Japan)), Yoshiyuki Yoneda(Daiichi-Sankyo (Japan)), Shin Iimura(Daiichi-Sankyo (Japan)), Jun Chiba(Daiichi-Sankyo (Japan)), Keiko Matsumoto(Kagawa University), Mika Yokoyama(Daiichi-Sankyo (Japan)), Tomoe Taira(Daiichi-Sankyo (Japan)), Tohru Takashi(Daiichi-Sankyo (Japan)), Atsushi Nakayama(The University of Osaka)
Cited by 25
Related Papers
Detection of bone metastases in non‐small cell lung cancer patients: Comparison of whole‐body diffusion‐weighted imaging (DWI), whole‐body MR imaging without and with DWI, whole‐body FDG‐PET/CT, and bone scintigraphy
|Journal of Magnetic Resonance Imaging|2009|183
Differentiation of Malignant and Benign Pulmonary Nodules with Quantitative First-Pass 320–Detector Row Perfusion CT versus FDG PET/CT
|Radiology|2011|129
Diffusion-Weighted MRI Versus 18F-FDG PET/CT: Performance as Predictors of Tumor Treatment Response and Patient Survival in Patients With Non–Small Cell Lung Cancer Receiving Chemoradiotherapy
|American Journal of Roentgenology|2011|128